John Meekin

455 total citations
7 papers, 178 citations indexed

About

John Meekin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, John Meekin has authored 7 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in John Meekin's work include CAR-T cell therapy research (3 papers), Liver physiology and pathology (2 papers) and Cancer therapeutics and mechanisms (1 paper). John Meekin is often cited by papers focused on CAR-T cell therapy research (3 papers), Liver physiology and pathology (2 papers) and Cancer therapeutics and mechanisms (1 paper). John Meekin collaborates with scholars based in United States, Japan and Netherlands. John Meekin's co-authors include Nazzareno Dimasi, Cui Chen, Emil F. Michelotti, Jonathan Rios‐Doria, Leslie Wetzel, Philip Martin, Binyam Bezabeh, Andrew Buchanan, Raymond Rothstein and Kelly McGlinchey and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Cytotherapy.

In The Last Decade

John Meekin

6 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Meekin United States	5	139	87	37	21	16	7	178
L.B.J. van Iersel Netherlands	7	58 0.4×	20 0.2×	23 0.6×	14 0.7×	71 4.4×	7	152
Kevin Schifferli United States	7	78 0.6×	69 0.8×	74 2.0×	85 4.0×	3 0.2×	12	217
Míriam Arumí Spain	5	113 0.8×	37 0.4×	33 0.9×	9 0.4×	17 1.1×	13	172
Marie Mack United States	5	83 0.6×	24 0.3×	54 1.5×	41 2.0×	26 1.6×	7	193
Youpei Lin China	7	62 0.4×	23 0.3×	74 2.0×	29 1.4×	20 1.3×	15	173
Lu Pei China	10	73 0.5×	45 0.5×	124 3.4×	42 2.0×	23 1.4×	20	227
Spencer H. Shao United States	8	116 0.8×	11 0.1×	26 0.7×	16 0.8×	4 0.3×	13	167
Verónica Robles United States	5	125 0.9×	131 1.5×	65 1.8×	12 0.6×		13	175
Karie Runcie United States	6	114 0.8×	62 0.7×	101 2.7×	69 3.3×	2 0.1×	27	227
Josh Snyder United States	5	122 0.9×	77 0.9×	66 1.8×	18 0.9×		6	189

Countries citing papers authored by John Meekin

Since Specialization

Citations

This map shows the geographic impact of John Meekin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Meekin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Meekin more than expected).

Fields of papers citing papers by John Meekin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Meekin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Meekin. The network helps show where John Meekin may publish in the future.

Co-authorship network of co-authors of John Meekin

This figure shows the co-authorship network connecting the top 25 collaborators of John Meekin. A scholar is included among the top collaborators of John Meekin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Meekin. John Meekin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Dyk, Dewald van, Peter Zanvit, Christine Fazenbaker, et al.. (2023). Abstract LB085: Antitumor activity of AZD0754, a dnTGFbRII armored STEAP2 targeted CAR-T therapy, in preclinical models of prostate cancer. Cancer Research. 83(8_Supplement). LB085–LB085. 1 indexed citations

Torchia, Maria Letizia Giardino, Ashley A. Merlino, Erin Sult, et al.. (2022). Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy. Cytotherapy. 24(7). 720–732. 7 indexed citations

Kinneer, Krista, John Meekin, Arnaud Tiberghien, et al.. (2018). SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads. Clinical Cancer Research. 24(24). 6570–6582. 58 indexed citations

Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies. Cancer Research. 77(10). 2686–2698. 91 indexed citations

Rios‐Doria, Jonathan, Jay Harper, Raymond Rothstein, et al.. (2017). Abstract 4596: Antibody-drug conjugates bearing pyrrolobenzodiazepine or tubulysin payloads alter the tumor immune microenvironment and synergize with multiple immunotherapies. Cancer Research. 77(13_Supplement). 4596–4596. 1 indexed citations

Talbot, Neil C., Thomas J. Caperna, Ryan R. Willard, John Meekin, & Wesley M. Garrett. (2010). Characterization of Two Subpopulations of the PICM-19 Porcine Liver Stem Cell Line for use in Cell-Based Extracorporeal Liver Assistance Devices. The International Journal of Artificial Organs. 33(6). 348–361. 10 indexed citations

Willard, Ryan R., Nancy W. Shappell, John Meekin, Neil C. Talbot, & Thomas J. Caperna. (2009). Cytochrome P450 expression profile of the PICM-19H pig liver cell line: potential application to rapid liver toxicity assays. In Vitro Cellular & Developmental Biology - Animal. 46(1). 11–19. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact